New Shockwave IVL Catheter to Debut at #TCT2023
Shockwave Medical, will be introducing their latest iteration of the intravascular Lithotripsy Catheter, the C2+, just approved by the U.S. FDA. The C2+ provides 50% more pulses and, according to Dr. Richard Shlofmitz of St. Francis Hospital in Roslyn, NY,"will be an added benefit of IVL for optimally treating complex calcium, including more diffuse disease, as well as nodular and thick, eccentric calcium." (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - October 22, 2023 Category: Cardiology Source Type: news
Medtronic's Evolut FX TAVI System Gets CE Mark
Medtronic today announced that its latest iteration of the Evolut TAVI/TAVR system, the Evolut ™ FX, has received the CE (Conformité Européenne) Mark. Although medical devices often are approved in Europe prior to US approval, the Evolut FX did the opposite: it garnered US FDA approval two years ago. Today's announcement means that this newest and most advanced transcatheter platform for treating severe aortic stenosis will now be available in Europe and beyond. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - October 13, 2023 Category: Cardiology Source Type: news
"It's Time!" Say the Major Cardiology Organizations Regarding a Change to the Process of Physician Certification
They no longer wish to be subject to certification by the American Board of Internal Medicine (ABIM) and are addressing the long-standing complaints of a wide range of cardiologists who claim that the certification requirements of ABIM are not in any way related to their day-to-day practice, are needlessly time-consuming, and are expensive. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - September 22, 2023 Category: Cardiology Source Type: news
Boston Scientific Announces FDA Approval for the Latest-Generation WATCHMAN FLX ™ Pro Left Atrial Appendage Closure Device
Designed to further advance the procedural performance and safety of the WATCHMAN technology, which is indicated to reduce stroke risk in patients with non-valvular atrial fibrillation (NVAF) who need an alternative to oral anticoagulation therapy, the device now features a polymer coating, visualization markers and a broader size matrix to treat a wider range of patients. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - September 8, 2023 Category: Cardiology Source Type: news
Interview with Dr. B. Clay Sizemore About Calcium Modification with IVL in Hospitals That Do Not Have Surgical Backup
In this interview, Dr. Sizemore discusses how intravascular lithotripsy (IVL) has been a game-changer for patients with significant calcified lesions -- that instead of having to transport them to a distant hospital, he is able to safely and efficaciously treat them in Thomasville, Georgia. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - August 12, 2023 Category: Cardiology Source Type: news
Centers For Medicare and Medicaid Services Creates New Hospital Inpatient Payment for Coronary Intravascular Lithotripsy
Shockwave Medical, Inc. (NASDAQ: SWAV) announced today that as part of the Fiscal Year 2024 Medicare Hospital Inpatient Prospective Payment System (IPPS) final rule, the Centers for Medicare and Medicaid Services (CMS) has created new Medicare Severity Diagnosis Related Group (MS-DRG) codes and payments for coronary Intravascular Lithotripsy (IVL) in the hospital inpatient setting. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - August 9, 2023 Category: Cardiology Source Type: news
Medtronic Receives FDA Approval For Its Next Generation Micra Leadless Pacing Systems
Medtronic plc (NYSE: MDT) today announced it has received U.S. Food and Drug Administration (FDA) approval of its Micra ™ AV2 and Micra™ VR2, the next generation of its industry-leading miniaturized, leadless pacemakers. Micra AV2 and Micra VR2, the world's smallest pacemakers, provide longer battery life and easier programming than prior Micra pacemakers, while still delivering the many benefits of leadless paci ng such as reduced complications compared to traditional pacemakers. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - May 9, 2023 Category: Cardiology Source Type: news
SCCT Honors Dr. Martha Gulati with 2023 Arthur S. Agatston Award
The Society of Cardiovascular Computed Tomography (SCCT) Board of Directors is proud to announce that Martha Gulati, MD, FACC, FAHA, FASPC, FESC has been named the recipient of the 2023 Arthur S. Agatston Cardiovascular Disease Prevention Award for her extensive contributions to the study of women and cardiac diseases and to efforts to improve women ’s healthcare. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - May 4, 2023 Category: Cardiology Source Type: news
Three-Year Results of Medtronic's Evolut TAVR Compared to Surgery in Low Risk Patients
Presented at ACC
The 3-year comparative data for Medtronic's CoreValve/Evolut TAVR vs. SAVR for low risk patients that were presented at today's late-breaking clinical trials session were much needed and the results showed that this device compared favorably with surgery and, in some respects, was superior. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - March 7, 2023 Category: Cardiology Source Type: news
Medtronic CoreValve/Evolut ™ Demonstrates Best Durability
Medtronic today announced five-year bioprosthetic valve dysfunction (BVD) data for the CoreValve/Evolut ™ platform, the first and only transcatheter aortic valve replacement (TAVR) platform to show significantly better valve performance and durability compared to surgical aortic valve replacement (SAVR) at five years. Data, presented by Dr. Steven Yakubov, in a late-breaking clinical trial session a t the 2023 annual meeting of Cardiovascular Research Technologies (CRT 2023), build upon the excellent results of the structural valve deterioration (SVD) analysis recently published in JAMA Cardiology. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - February 27, 2023 Category: Cardiology Source Type: news
Medtronic Continues to Make Significant Advances as an Inclusion, Diversity and Equity Leader
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, announced that it joins 483 other global companies as a member of the 2023 Bloomberg Gender-Equality Index (GEI), a modified market capitalization-weighted index developed to gauge the performance of public companies dedicated to reporting gender-related data. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - February 8, 2023 Category: Cardiology Source Type: news
Updated SCAI Guidance Includes Coronary IVL as a Treatment Option in All U.S. Catheterization Labs Regardless of Surgical Backup Status
Shockwave Medical, Inc. announced that coronary IVL was included in a treatment guidance document published by the Society of Cardiovascular Angiography and Intervention (SCAI) as a potential therapeutic option in all U.S. catheterization labs. - including facilities without on-site surgical backup. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - January 31, 2023 Category: Cardiology Source Type: news
TCT 2022: SYMPLICITY HTN-3 Trial Data Show Sustained Long-Term Blood Pressure Reductions With Medtronic Renal Denervation Procedure
Subjects who underwent radiofrequency renal denervation (RF RDN) with the first generation Symplicity ™ renal denervation system, had a statistically significant reduction in office and ambulatory blood pressure compared to subjects in the sham control group. The data were presented today as Late-Breaking Clinical Science at the 34th Transcatheter Cardiovascular Therapeutics (TCT) conference, the annual scientific symposium of the Cardiovascular Research Foundation, and published simultaneously in The Lancet. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - September 18, 2022 Category: Cardiology Source Type: news
Medtronic Launches Newest Drug-Eluting Stent: The Onyx Frontier ™
The major improvement is that it employs a more deliverable system: an innovative dual-layer balloon, a lower profile for crossing, and increased catheter flexibility. These refinements point to a 16% improvement in deliverability vs. the previous generation while maintaining superior radial strength. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - August 25, 2022 Category: Cardiology Source Type: news
New US Population Study Projects Steep Rise in Cardiovascular Diseases by 2060
Study projects substantial changes in the prevalence of CV risk factors and disease in the U.S. population by 2060, with an increasing prevalence among Black and Hispanic populations who have historically experienced poor access to quality health care. Targeted efforts toward improved screening and equitable access to quality health care in populations with the greatest growth in CV risk factors or disease would be expected to have a substantial impact to reduce future CV risk for the population overall. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - August 1, 2022 Category: Cardiology Source Type: news
